BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder
NCT03193398
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
104
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
BTRX-246040 oral capsule(s)
DRUG:
Placebo oral capsule(s)
Sponsor
BlackThorn Therapeutics, Inc.